Enzolytics Inc (ENZC)

[Chapala 1]

ImmunoTech Laboratories BG-Europe has filed for a mass use permit, Phase IV, in Bulgaria. Enzolytics is seeking a Contract Manufacturing Organization (CMO) in the United States to produce the Immunotherapy Treatment to be used as the validation batch in coordination with the Bulgarian regulatory authority and Immunotech BG-Europe.

Additionally, ImmunoTech BG-Europe has informed Enzolytics that they will be seeking to register the ImmunH product as a Immune Modulator, allowing use as an adjunct in additional applications to regulate or normalize the Immune System.



this would allow piggyback on other drugs and that's huge![color=red][/color]